| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184709 | Gynecologic Oncology | 2016 | 5 Pages |
Abstract
Oral progestin therapy for conservative treatment of young EMC/CAH survivors is associated with increased weight gain, especially when megestrol acetate is utilized. Utilization of LNG-IUD may result in less weight gain.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Diana Cholakian, Kari Hacker, Amanda N. Fader, Paola A. Gehrig, Edward J. III,